THE SHARE: Change: 0.00 SEK (-0.92%) / Price: 0.22 SEK / Apr 17, 2025, 1:30 pm (CEST)

Home
About
Technology
Portfolio
Investor Relations
Media
Contact
- Contact us

4 Apr, 2025

Spago on the increased dose in Tumorad-01

About Spago Nanomedical

Spago Nanomedical AB is a Swedish nanomedicines company in clinical development phase. The company´s development projects are based on a platform of polymeric materials with unique properties for more precise diagnosis and treatment of life-threatening and debilitating diseases.

Address

Spago Nanomedical AB
Scheelevägen 22
SE-223 63 Lund
Sweden

Contact

Phone: +46 46 811 88
LinkedIn